e-learning resources

Annual Congress Glasgow 2004

Saturday, 04.09.2004
Sunday, 05.09.2004
Monday, 06.09.2004
Tuesday, 07.09.2004
Wednesday, 08.09.2004

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 24: Suppl. 48, abstract number.

Material from 2004:

3888 Abstracts
555 Slide presentations
20 Webcasts
96 Handouts

Material from 2004: Show

Treatment of pulmonary hypertension

Oral Presentation
Chairs: O. Sitbon (Clamart, France), S. Gaine (Dublin, Ireland)

Download all media

Download all media

Comparison of acute hemodynamic effects of three different phosphodiesterase inhibitors in patients with pulmonary arterial hypertension H. A. Ghofrani, R. Voswinckel, F. Reichenberger, M. G. Kohstall, H. Olschewski, R. T. Schermuly, N. Weissmann, J. Y. Berney, W. Seeger, F. Grimminger (Giessen, Germany; Geneva, Switzerland)
Intravenous iloprost as "rescue therapy" in patients with severe primary pulmonary hypertension deteriorating while on chronic aerosolized iloprost therapy C. F. Opitz, R. Wensel, S. Lodziewski, S. B. Felix, R. Ewert (Berlin, Regensburg, Greifswald, Germany)
Hemodynamic testing of acute vasoreagibility to sildenafil in patients with severe pulmonary hypertension C. Marx, S. C. Steffen, H. Michael, H. Gert (Dresden, Germany)
Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease J. E. Park, A. Sheth, T. B. Ho, B. P. Madden (London, United Kingdom)
The endothelin-receptor antagonist bosentan for the treatment of pulmonary arterial hypertension (PAH) associated with congenital heart defects (CHD) O. Sitbon, M. Beghetti, J. Petit, L. Iserin, M. Humbert, V. Gressin, G. Simonneau (Clamart, Le Plessis Robinson, Paris, France; Geneva, Switzerland)
Open label study of bosentan in chronic thromboembolic pulmonary hypertension P. George, D. Hodgkins, N. Morrell, J. Pepke Zaba (Cambridge, United Kingdom)
Sitaxsentan sodium for the treatment of pulmonary hypertension(PAH) in patients failing bosentan: preliminary single center data A. Frost, H. Purl (Houston, United States Of America)
Long-term sitaxsentan therapy in PAH E. Horn, D. Langleben, A. Frost, R. Oudiz, R. J. Barst (New York, Houston, Torrance, United States Of America; Montreal, Canada)

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.